About Axe Compute Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://predictive-oncology.com/
Frequently Asked Questions
What is the 52-week range for AGPU?
The 52-week high is $15.15 and the 52-week low is $1.03.
What is the P/E ratio for AGPU?
The P/E ratio data is currently unavailable.
What is the dividend yield for AGPU?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -432.29%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -7769.80%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.56.
Analyst Recommendation Trends
Wall Street analyst consensus for AGPU over the last few months:
Latest AGPU News
Axe Compute Receives More Than $184 Million in Customer Prepayments and Signs Over $266 Million in New AI Infrastructure Contracts Since Q2 Earnings Call
New agreements bring the total value of contracts signed over the past seven months to more than $3.45 billionPITTSBURGH, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Axe Compute Inc. (NASDAQ: AGPU) today announced that it has received more than $184 million in customer prepayments and signed over $266 million in new AI infrastructure contracts since reporting second-quarter results on August 17, 2026. The prepayments, drawn from both newly signed agreements and existing contracts, represent capital commi
Axe Compute Receives Over $266M In New AI Infrastructure Contracts Since Aug. 17
Axe Compute Inc. (NASDAQ: AGPU) today announced that it has received more than $184 million in customer prepayments and signed over $266 million in new AI infrastructure contracts since reporting second-quarter results
Axe Compute Just Sold Its Cancer Business to Become an AI Stock
Axe Compute stock has rallied over 650% in the past six months as investors increasingly value it as an AI infrastructure stock. The challenge is now delivering on that promise.
Why DataMEDS’ Acquisition Does Not Seem to Be Very Bullish for MEDS Stock at This Point
The low purchase price of Helomics and low revenue suggest that the acquisition is not that promising for DataMEDS AI.
Full Transcript: Axe Compute Q2 2026 Earnings Call
Axe Compute (NASDAQ:AGPU) held its second-quarter earnings conference call on Monday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our
DataMEDS AI Completes $1.5 Million Helomics Acquisition, Expanding into Cancer Diagnostics
The transaction adds a certified oncology laboratory, contract research services and $1. 5 million in cash to DataMEDS, while Axe Compute exits its remaining cancer testing business.
One stock quietly did 590% in 2026 after a decisive AI rebranding
The company now rents out AI computing power as Axe Compute.
DataMEDS AI Stock Surges Wednesday: What's Driving the Action?
DataMEDS AI is surging Wednesday as investors digest the acquisition of an AI cancer diagnostics lab and contract research businesses.
Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
Tempest shares surged 49.6% on a Senlang CD7 CAR-T option deal, while several small-cap stocks posted sharp premarket gains and losses.
DataMEDS AI Stock Soars 65% Pre-market: Here's What You Need to Know
DataMEDS AI shares jumped 8.02% in overnight session Tuesday after the company completed its $1.5 million Helomics acquisition.
DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute
Acquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand Services into Cancer ManagementPITTSBURGH, PA / ACCESS Newswire / September 15, 2026 / (NASDAQ:MEDS) ("DataMEDS"), a Health IT company vertically integrating health data acquisition and transfer, today announced that it completed the acquisition of artificial intelligence cancer diagnostics laboratory business Helomics Corporation ("Helomics") from Axe Compute Inc. (NASDAQ:AGPU) ("Axe Compute" or the "Company
Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform
All-stock sale gives Axe Compute equity stake in DataMEDS AI; aligns APU’s operating structure with its scaling GPU-as-a-Service businessPITTSBURGH, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Axe Compute Inc. (NASDAQ: AGPU) ("Axe Compute" or the "Company"), a neocloud AI infrastructure platform, today announced the sale of its legacy artificial intelligence cancer diagnostics laboratory business Helomics Corporation (“Helomics”) to DataMEDS AI, Inc. (NASDAQ: MEDS) ("DataMEDS"), a Health IT company verti
Axe Compute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PITTSBURGH, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Axe Compute Inc. (NASDAQ: AGPU) (the “Company”) today announced that it has granted a non-qualified stock option to purchase 60,000 shares of the Company’s common stock to one non-executive individual as an inducement material to the individual's acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The option was not granted under the Company’s 2024 Equity Incentive Plan. The stock option has an exercise price
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-08 | Zhu Theodore | +3,750 | $11.72 | $43,950 |
| 2026-09-08 | Zhu Theodore | +5,000 | $10.875 | $54,375 |
| 2026-07-01 | Zhu Theodore | +2,420 | - | - |
| 2026-07-01 | ST. CLAIR GREGORY SR | +2,420 | - | - |
| 2026-07-01 | Hawryluk Matthew | +1,716 | - | - |
| 2026-07-01 | HANDLEY DANIEL E | +1,716 | - | - |
| 2026-07-01 | Nuzum Charles Lee Sr | +2,420 | - | - |
| 2026-05-29 | Zhu Theodore | +11,250 | $6.61 | $74,363 |
| 2026-05-28 | Zhu Theodore | +3,750 | $6.61 | $24,788 |
| 2026-05-14 | Blacher Joshua | +9,389 | - | - |
| 2026-04-20 | Zhu Theodore | +5,144 | - | - |
| 2026-04-20 | Nuzum Charles Lee Sr | +14,082 | - | - |
| 2026-04-20 | ST. CLAIR GREGORY SR | +9,419 | - | - |
| 2026-04-20 | Hawryluk Matthew | +6,782 | - | - |
| 2026-04-20 | HANDLEY DANIEL E | +5,663 | - | - |
| 2026-04-16 | Yaukey-Witter Jeremy Reese | +225,000 | - | - |
| 2026-04-01 | Okamoto Kyle Robert | +300,000 | - | - |
| 2026-03-06 | Rao Veena | +4,197 | - | - |
| 2026-03-06 | Matthews Shawn | +1,166 | - | - |
| 2026-02-09 | MIGLINO CHRISTOPHER | +500,000 | - | - |
| 2026-02-05 | Vennare Raymond F | -6,758 | $2.59 | $17,503 |
| 2025-12-10 | Vennare Raymond F | +20,000 | - | - |